metastatic colorectal cancer (mCRC)
Showing 1 - 25 of >10,000
Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)
Not yet recruiting
- Metastatic Colorectal Cancer (mCRC)
- JMT101
- +3 more
- (no location specified)
Oct 13, 2023
Tislelizumab, Bevacizumab, Oxaliplatin Trial in Beijing (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)
Recruiting
- Tislelizumab
- +7 more
-
Beijing, ChinaLin Yang
Jul 21, 2023
Metastatic Colorectal Cancer Trial run by the National Cancer Institute (NCI) (Retifanlimab, Therapeutic CEA, Brachyury and MUC1
Not yet recruiting
- Metastatic Colorectal Cancer
- Retifanlimab
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 4, 2023
Overall Survival in Metastatic Colorectal Cancer (mCRC)
Completed
- Metastatic Colorectal Cancer (mCRC)
-
Princeton, New JerseyLocal Institution
Jun 13, 2022
Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer, Liver Cancer Trial in Grafton (Eye90 Microspheres)
Recruiting
- Hepatocellular Carcinoma Non-resectable
- +2 more
- Eye90 Microspheres
-
Grafton, New ZealandAuckland District Health Board
Jan 30, 2023
CCR5, Microsatellite Stable, Metastatic Trial (700mg leronlimab weekly dose, 80mg Regorafenib at week 1, 120mg Regorafenib at
Withdrawn
- CCR5
- +3 more
- 700mg leronlimab weekly dose
- +3 more
- (no location specified)
Feb 15, 2023
Metastatic Colorectal Cancer, mCRC Trial in Shenyang (HLX208)
Recruiting
- Metastatic Colorectal Cancer
- mCRC
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital
May 1, 2022
Metastatic Colorectal Cancer Trial in India (Regorafenib (Stivarga, BAY73-4506))
Active, not recruiting
- Metastatic Colorectal Cancer
- Regorafenib (Stivarga, BAY73-4506)
-
Hyderabad, Andhra Pradesh, India
- +12 more
Jan 13, 2023
Called STAR-T to Learn More About Sequential Treatment With
Not yet recruiting
- Metastatic Colorectal Cancer (mCRC)
- Regorafenib (BAY73-4506, Stivarga®)
- +2 more
-
Whippany, New JerseyMany locations
Apr 21, 2023
Colon Cancer Liver Metastasis Trial in United States (Lyso-Thermosensitive Liposomal Doxorubicin, 5% Dextrose Solution,
Terminated
- Colon Cancer Liver Metastasis
- Lyso-Thermosensitive Liposomal Doxorubicin
- +2 more
-
Los Angeles, California
- +3 more
Sep 15, 2022
Metastatic Colorectal Cancer, No Evidence of Disease Status, ctDNA Monitoring Trial in Shanghai (ctDNA and adjuvant therapy,
Recruiting
- Metastatic Colorectal Cancer
- +2 more
- ctDNA and adjuvant therapy
- ctDNA
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 22, 2022
New Patient Stratification Tools in MSS RAS mt mCRC
Completed
- Advanced Colorectal Cancer
-
Heidelberg, Germany
- +9 more
Nov 25, 2022
CRC Trial in Beijing (HL-085, Vemurafenib)
Not yet recruiting
- CRC
-
Beijing, Beijing, ChinaBeijing Oncology Hospital
Feb 6, 2022
Metastatic Colorectal Cancer, MSS Trial in Heidelberg (Pembrolizumab, Maraviroc)
Completed
- Metastatic Colorectal Cancer
- MSS
- Pembrolizumab
- Maraviroc
-
Heidelberg, GermanyNational Center for Tumor Diseases, University Hospital Heidelbe
May 17, 2022
Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer
Recruiting
- Metastatic Colorectal Cancer (Mcrc)
- +7 more
- Floxuridine
- +8 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Metastatic Colorectal Cancer Trial in Providence (Dose level 1 ONC201 625mg, Dose level 2 ONC201 500mg, Dose level 3 ONC201
Terminated
- Metastatic Colorectal Cancer
- Dose level 1 ONC201 625mg
- +2 more
-
Providence, Rhode IslandLifespan Cancer Institute: The Miriam and Rhode Island Hospitals
May 25, 2022
Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))
Active, not recruiting
- Metastatic Colorectal Cancer
- Aflibercept
- +4 more
-
Madrid, SpainSpanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022
Metastatic Colorectal Cancer Trial in Duarte, St Leonards (Magrolimab, Bevacizumab, Irinotecan)
Recruiting
- Metastatic Colorectal Cancer
- Magrolimab
- +4 more
-
Duarte, California
- +19 more
Jan 27, 2023
Metastatic Colorectal Cancer (mCRC) Trial in Nanjing (HLX04 100 mg in 4 ml Injection, Avastin 100 mg in 4 ml Injection)
Active, not recruiting
- Metastatic Colorectal Cancer (mCRC)
- HLX04 100 mg in 4 ml Injection
- Avastin 100 mg in 4 ml Injection
-
Nanjing, Jiangsu, ChinaNanjing Bayi Hospital Ethics Committee
May 6, 2022
CRC Trial in Shanghai (HLX208, Cetuximab Injection [Erbitux])
Recruiting
- CRC
- HLX208
- Cetuximab Injection [Erbitux]
-
Shanghai, ChinaFudan University Affiliated Oncology Hospital
Dec 30, 2021
Metastatic Colorectal Cancer (mCRC) Trial in France (Regorafenib, Irinotecan)
Recruiting
- Metastatic Colorectal Cancer (mCRC)
-
Nice, Alpes-Maritimes, France
- +10 more
Jan 16, 2023
Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Trifluridine/Tipiracil)
Recruiting
- Metastatic Colorectal Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 24, 2023